NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
30,850
-1,600 (-4.93%)
At close: Feb 6, 2026
96.87%
Market Cap350.61B +90.2%
Revenue (ttm)32.96B +44.5%
Net Income3.11B
EPSn/a
Shares Out11.36M
PE Ratio112.60
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume102,619
Average Volume173,662
Open30,700
Previous Close32,450
Day's Range30,000 - 31,450
52-Week Range12,800 - 54,300
Beta0.70
RSI32.85
Earnings DateAug 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is based in Jincheon-eup, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 96
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.

Financial Statements